A prospective study to compare levonogestrol intrauterine system and trans-cervical resection of endometrium for treatment of abnormal uterine bleeding

Kishorkumar V. Hol, Shraddha S. Shastri, Shilpa S. Magar, Sameer P. Darawade


Background: This article is a study comparing the two most accepted forms of treatment for abnormal uterine bleeding - levonorgestrol intrauterine treatment and transcervical resection of endometrium, with regards to its acceptability, efficacy, adverse effects and user satisfaction. Aim of this study was to compare the acceptability, efficacy, adverse effects and user satisfaction of LNG-IUS and TCRE for treatment for AUB.

Methods: A prospective observational study conducted in SKNMC and GH. Forty-nine women with abnormal uterine bleeding after hysteroscopic evaluation were included in this study; where 17 opted for LNG-IUS; 32 opted for TCRE with bipolar electrode. 15 patients in LNG-IUS group and 28 pts in TCRE group completed follow up. Menstrual pattern, pictorial blood loss assessment chart score, adverse effects, acceptability, satisfaction and reason for discontinuation were recorded at 6 weeks, 6 months and 12 months after the procedure. Prior to LNG-IUS insertion or endometrial ablation, endometrial and cervical pathology were excluded by D and C and cervical smear, respectively. TVUS was used to exclude possible causes of menorrhagia, including myomas and endometrial polyp as well as adnexal pathology. LNG-IUS insertion was performed as an office procedure one day after cessation of menstrual bleeding with a negative urine pregnancy test.

Results: Menstrual blood loss reductions in TCRE and LNG-IUS groups were by 85.7% and 87.6% respectively after a year. Amenorrhoea was more common in TCRE group while spotting and systemic effects were more common in LNG-IUS group. Satisfaction and acceptance rates are higher in TCRE group.

Conclusions: The TCRE and LNG-IUS are equally effective in reducing bleeding in AUB patients. Acceptance and satisfaction are better with TCRE, as a modality of treatment for AUB.


Abnormal uterine bleeding, Amenorrhea, Endometrium, Levonorgesterol intrauterine system, Transcervical resection of menorrhagia

Full Text:



Blumenthal PD, Dawson L, Hurskainen R. Cost-effectiveness and quality of life associated with heavy menstrual bleeding among women using the levonorgestrel-releasing intrauterine system. Int J Gynaecol Obstet. 2011;112:171-8.

Theodoridis TD, Zepiridis L, Zafrakas M, Grimbizis G, Tantsis A, Kyrou D, et al. Levonorgestrel-releasing intrauterine system vs.endometrial thermal ablation for menorrhagia. Hormones (Athens). 2009;8:60-4.

Milsom I. The levonorgestrel -releasing intrauterine system as an alternative to hysterectomy in peri-menopausal women. Contraception. 2007;75(6 Suppl):S152.

Endrikat J, Vilos G, Muysers C, Fortier M, Solomayer E, Lukkari-Lax E. The levonorgestrel-releasing intrauterine system provides a reliable, long-term treatment option for women with idiopathic menorrhagia. Arch Gynecol Obstet. 2012;285:117-21.

Tariq N, Ayub R, Jaffery T, Rahim F, Naseem F, Kamal M. Efficacy of levonorgestrel intrauterine system (LNG-IUS) for abnormal uterine bleeding and contraception. J Coll Physicians Surg Pak. 2011;21:210-3.

Vilos GA, Marks J, Tureanu V, Abu-Rafea B, Vilos AG. The levonorgestrel intrauterine system is an effective treatment in selected obese women with abnormal uterine bleeding. J Minim Invasive Gynecol. 2011;18:75-80.

Rodriguez MI, Darney PD. Non-contraceptive applications of the levonorgestrel intrauterine system. Int J Womens Health. 2010;2:63-8.

American College of Obstetricians and Gynecologists Committee on Gynecologic Practice. ACOG committee opinion. No. 337: Noncontraceptive uses of the levonorgestrel intrauterine system. Obstet Gynecol. 2006;107:1479-82.

Maresh MJA, Metcalfe MA, McPherson K, Overton C, Hall V, Hargreaves J. The VALUE national hysterectomy study: description of the patients and their surgery. Br J Obstet Gynaecol. 2002;109:302-12.

Abbott J, Garry R. The surgical management of menorrhagia. Hum Reprod Update. 2002;8:78.

Lethaby AE, Cooke I, Rees M. Progesterone or progestogen-releasing intrauterine systems for heavy menstrual bleeding. Cochrane Database Syst Rev. 2005;4:CD002126.

Ghazizadeh S, Bakhtiari F, Rahmanpour H, Davari-Tanha F, Ramezanzadeh F. A randomized clinical trial to compare levonorgestrel-releasing intrauterine system (Mirena) vs trans-cervical endometrial resection for treatment of menorrhagia. Int J Womens Health. 2011;3:207-11.

Gupta B, Mittal S, Misra R, Dek D, Dadhwal V. Levonorgestrel-releasing intrauterine system vs transcervical endometrial resection for dysfunctional uterine bleeding. Inter J Gynecol Obstet. 2006;95:261-6.

Crosignani PG, Vercellini P, Mosconi PM, Sci DB, Oldani S, Cortesi I, et al. Levonorgestrel-releasing intrauterine device versus hysteroscopic endometrial resection in the treatment of dysfunctional uterine bleeding. Obstet Gynecol. 1997;90:257-63.

Istre O, Trolle B. Treatment of menorrhagia with the levonorgestrel intra uterine system versus endometrial resection. Fertil Steril. 2001;76:304-9.

Hidalgo M, Bahamondes L, Perrotti M, Diaz J, Dantas-Monteiro C, Carlos P. Bleeding patterns and clinical performance of the levonorgestrel releasing intrauterine system (Mirena) up to two years. Contraception. 2002;65:129-32.